BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34043932)

  • 1. Heterogeneity in myasthenia gravis: considerations for disease management.
    Evoli A; Spagni G; Monte G; Damato V
    Expert Rev Clin Immunol; 2021 Jul; 17(7):761-771. PubMed ID: 34043932
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
    Beecher G; Putko BN; Wagner AN; Siddiqi ZA
    Drugs; 2019 Mar; 79(4):353-364. PubMed ID: 30762205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional and emerging treatments and controversies in myasthenia gravis.
    Evoli A; Damato V
    Expert Rev Neurother; 2023 May; 23(5):445-456. PubMed ID: 37102669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis. Update on diagnosis and therapy.
    García Estévez DA; Pardo Fernández J
    Med Clin (Barc); 2023 Aug; 161(3):119-127. PubMed ID: 37248131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis: recent advances in immunopathology and therapy.
    Lee JI; Jander S
    Expert Rev Neurother; 2017 Mar; 17(3):287-299. PubMed ID: 27690672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis: new developments in research and treatment.
    Evoli A
    Curr Opin Neurol; 2017 Oct; 30(5):464-470. PubMed ID: 28654435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia and the neuromuscular junction.
    Gilhus NE
    Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis. Pathogenesis and current concepts in management.
    Havard CW; Scadding GK
    Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian recommendations for the diagnosis and treatment of myasthenia gravis.
    Evoli A; Antonini G; Antozzi C; DiMuzio A; Habetswallner F; Iani C; Inghilleri M; Liguori R; Mantegazza R; Massa R; Pegoraro E; Ricciardi R; Rodolico C
    Neurol Sci; 2019 Jun; 40(6):1111-1124. PubMed ID: 30778878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis-Pathophysiology, diagnosis, and treatment.
    Tannemaat MR; Huijbers MG; Verschuuren JJGM
    Handb Clin Neurol; 2024; 200():283-305. PubMed ID: 38494283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of seronegative myasthenia garvis].
    Motomura M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):877-9. PubMed ID: 18210824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and management of myasthenia gravis.
    Keesey JC
    Muscle Nerve; 2004 Apr; 29(4):484-505. PubMed ID: 15052614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming challenges in the diagnosis and treatment of myasthenia gravis.
    Evoli A; Iorio R; Bartoccioni E
    Expert Rev Clin Immunol; 2016; 12(2):157-68. PubMed ID: 26675896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune mediated neuromuscular junction defects.
    Farrugia ME; Vincent A
    Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular myasthenia gravis: a review and practical guide for clinicians.
    Shuey NH
    Clin Exp Optom; 2022 Mar; 105(2):205-213. PubMed ID: 35157811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis.
    Pourmand R
    Dis Mon; 1997 Feb; 43(2):65-109. PubMed ID: 9118787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.
    Evoli A; Padua L
    Autoimmun Rev; 2013 Jul; 12(9):931-5. PubMed ID: 23535158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.